MUMBAI -- Danish pharmaceutical major Novo Nordisk on Tuesday launched its Wegovy weight loss drug in India, debuting the medicine ahead of schedule and just months after American rival Eli Lilly began offering its own popular product in the country, which is grappling with rising obesity.
Pharmaceuticals
Novo Nordisk launches Wegovy in India as weight-loss market heats up
Early release comes months after rival Eli Lilly began offering its own drug
Boxes of Wegovy are displayed at a London pharmacy in early 2024. © Reuters
Read Next
Latest on Pharmaceuticals
